Mirella Nardo

7PUBLICATIONS
40CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 11, 2025
Pembrolizumab in Patients with Advanced Miscellaneous Rare Cancers: Results from a Phase 2 Basket Trial.

Mirella Nardo, Camila Braganca Xavier, Bettzy Stephen

|Apr 30, 2024
Clinical and Genomic Landscape of RAS Mutations in Gynecologic Cancers.

Ji Son, Yingao Zhang, Heather Lin

|May 25, 2023
Histological transformation to gliosarcoma with combined BRAF/MEK inhibition in BRAF V600E mutated glioblastoma.

Blessie Elizabeth Nelson, Neha K Reddy, Jason T Huse

|Aug 03, 2019
Primary splenic angiosarcoma: a rare entity often associated with rupture and hemoperitoneum.

Matheus Dalben Fiorentino, Jean Michel Correia Monteiro, Renata Elisie Barbalho de Siqueira

Pageof 2